[Federal Register Volume 64, Number 46 (Wednesday, March 10, 1999)]
[Notices]
[Page 11923]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5916]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel International Phase III IL-21 Study
Date: March 15, 1999.
Time: 11:00 a.m. to 1:30 p.m.
Agenda: To review and evaluate grant applications.
Place: 6130 Executive Boulevard, Rockville, MD 20852.
Contact Person: Olivia T. Preble, Scientific Review
Administrator, Grants Review Branch, Division of Extramural
Activities, National Cancer Institute, National Institutes of
Health, 6130 Executive Boulevard--Rm. 643B, Rockville, MD 20892-
7405, 301/496-7929.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: March 3, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5916 Filed 3-9-99; 8:45 am]
BILLING CODE 4140-01-M
